Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 147.79M | 126.97M | 127.37M | 100.75M | 82.65M |
Gross Profit | 46.13M | 41.05M | 38.73M | 26.57M | 27.78M |
EBITDA | 12.28M | 23.41M | 22.16M | 15.67M | 15.72M |
Net Income | -2.75M | 9.24M | 10.01M | 4.38M | 7.16M |
Balance Sheet | |||||
Total Assets | 174.75M | 175.61M | 170.36M | 159.38M | 158.22M |
Cash, Cash Equivalents and Short-Term Investments | 10.53M | 6.29M | 10.59M | 8.05M | 8.50M |
Total Debt | 43.56M | 37.86M | 38.41M | 42.40M | 44.10M |
Total Liabilities | 65.39M | 59.85M | 60.82M | 61.60M | 63.85M |
Stockholders Equity | 109.36M | 115.76M | 109.54M | 97.78M | 94.38M |
Cash Flow | |||||
Free Cash Flow | 11.35M | -702.00K | 14.03M | 3.83M | -1.85M |
Operating Cash Flow | 25.00M | 7.78M | 21.12M | 10.90M | 10.86M |
Investing Cash Flow | -13.34M | -8.29M | -7.09M | -6.98M | -12.71M |
Financing Cash Flow | -7.41M | -3.73M | -11.53M | -4.34M | 3.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | £298.87M | 25.45 | 4.26% | 232.49% | -4.39% | 33.44% | |
72 Outperform | £3.09B | 8.78 | 15.96% | 416.89% | -9.10% | 239.75% | |
66 Neutral | £614.05M | 20.67 | 6.65% | 8.44% | 4.75% | -3.29% | |
62 Neutral | £979.66M | ― | -5.93% | 1.05% | 0.71% | -274.39% | |
55 Neutral | £149.78M | 14.46 | -2.45% | 249.33% | 16.39% | -129.71% | |
52 Neutral | £159.80M | ― | -6.25% | ― | 0.81% | 15.63% | |
44 Neutral | AU$1.51B | -6.22 | -41.37% | 3.85% | -3.52% | -43.04% |
Zotefoams plc has announced that its directors and persons discharging managerial responsibilities have acquired shares under the company’s Share Incentive Plan. The purchase of shares, priced at £3.16 each, reflects the company’s commitment to aligning the interests of its management with those of its shareholders, potentially impacting its market positioning and stakeholder confidence.
Zotefoams plc announced that directors and persons discharging managerial responsibilities have acquired shares under the company’s Share Incentive Plan. This transaction, involving the purchase of partnership shares and allocation of matching shares, reflects the company’s commitment to aligning management interests with shareholder value, potentially impacting its market positioning and stakeholder confidence.
Zotefoams plc announced that its directors and persons discharging managerial responsibilities have acquired ordinary shares under the company’s Share Incentive Plan. This transaction, involving the purchase of dividend shares, reflects the company’s ongoing commitment to align the interests of its leadership with those of its shareholders, potentially impacting its market positioning and stakeholder confidence.
At its 2025 Annual General Meeting, Zotefoams plc successfully passed all resolutions, including ordinary and special resolutions, with a shareholder voting turnout of 53.51%. The approval of these resolutions, including the re-election of directors and authorization of share allotments, reflects strong shareholder support and positions the company for continued strategic growth and operational efficiency.
Zotefoams has reported a strong trading performance for the first four months of 2025, achieving an 8% sales growth and record revenue of £50.7 million. The company is executing a refreshed strategy, including restructuring its commercial function and expanding its manufacturing footprint in Vietnam, which is strategically important due to the concentration of the global athletic footwear market in Asia. Despite potential challenges from US tariffs, Zotefoams remains confident in its growth prospects, supported by robust margins, a growing order book, and strategic investments in North America and Asia.
Zotefoams plc announced that its directors and persons discharging managerial responsibilities have acquired shares under the company’s Share Incentive Plan. This acquisition, involving the purchase of partnership shares and allocation of matching shares, reflects the company’s commitment to aligning management interests with shareholder value, potentially strengthening its market position and stakeholder confidence.
Zotefoams plc announced the exercise of nil cost options by Group CFO Gary McGrath under the Deferred Bonus Share Plan, involving 2,125 ordinary shares at a price of £2.53 each. This transaction, reflecting dividends during the restricted period, aligns with the UK Market Abuse Regulation, potentially impacting shareholder value and executive compensation strategies.
Zotefoams plc announced the appointment of Nick Wright as the new Group Chief Financial Officer, effective by October 2025, succeeding Gary McGrath. Nick Wright brings over 20 years of experience in financial management and transformation, which aligns with Zotefoams’ strategic growth ambitions. His expertise in the manufacturing sector and listed company transformation will support Zotefoams’ next phase of growth, as expressed by Group CEO Ronan Cox.